Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study

[1]  J. Rello,et al.  Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes , 2015, Critical Care.

[2]  S. Nougaret,et al.  Diagnostic yield and safety of CT scans in ICU , 2015, Intensive Care Medicine.

[3]  G. Egerer,et al.  [Fungal infections in hematology patients and after blood stem cell transplantation: prophylaxis and treatment]. , 2014, Medizinische Klinik, Intensivmedizin und Notfallmedizin.

[4]  M. Netea,et al.  Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis , 2014, PloS one.

[5]  J. Mensa,et al.  [Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease]. , 2014, Revista iberoamericana de micologia.

[6]  John Moore,et al.  Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. , 2013, The Lancet. Infectious diseases.

[7]  A. Solé,et al.  Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient. , 2013, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[8]  T. Schmitt,et al.  Pilzinfektionen bei hämatologischen Patienten und nach Blutstammzelltransplantation , 2013, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[9]  D. Wichmann,et al.  Aspergillus Galactomannan Antigen for Diagnosis and Treatment Monitoring in Cerebral Aspergillosis , 2013, Progress in transplantation.

[10]  J. Baddley,et al.  Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes , 2013, BMC Infectious Diseases.

[11]  P. Olaechea,et al.  Epidemiología, diagnóstico y tratamiento de las infecciones fúngicas respiratorias en el paciente crítico , 2013 .

[12]  J. Rello,et al.  A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. , 2012, American journal of respiratory and critical care medicine.

[13]  B. Afessa,et al.  Diagnostic criteria for invasive pulmonary aspergillosis in critically ill patients. , 2012, American journal of respiratory and critical care medicine.

[14]  Q. Zhan,et al.  Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study , 2012, Critical Care.

[15]  J. Latgé,et al.  Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients , 2011, Journal of Clinical Microbiology.

[16]  N. Ampel,et al.  An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. , 2011, American journal of respiratory and critical care medicine.

[17]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  A. Wilmer,et al.  Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. , 2008, American journal of respiratory and critical care medicine.

[19]  W. Meersseman,et al.  Invasive aspergillosis in the ICU: an emerging disease , 2007, Intensive Care Medicine.

[20]  E. van Wijngaerden,et al.  Invasive aspergillosis in the intensive care unit. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Ager,et al.  Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. , 2006, Journal of critical care.

[22]  S. Blot,et al.  Aspergillosis in the ICU - The new 21st century problem? , 2006, Medical mycology.

[23]  F. Colardyn,et al.  Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients , 2006, Critical care.

[24]  A. Wilmer,et al.  Invasive aspergillosis in critically ill patients without malignancy. , 2004, American journal of respiratory and critical care medicine.

[25]  F. Colardyn,et al.  INVASIVE ASPERGILLOSIS IN CRITICALLY ILL PATIENTS: ANALYSIS OF RISK FACTORS FOR ACQUISITION AND MORTALITY , 2004, Acta clinica Belgica.

[26]  B. Plikaytis,et al.  Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.